Aktuellt
SENASTE
Redeye comments on Active Biotech’s initiation of the planned phase I trial with laquinimod. All of Active Biotech’s three main projects (naptumomab, tasquinimod and laquinimod) are now in the clinical phase.
LÄS MER
